You are here

China

Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready?

Pharma Voice

Fri, 12/6/24 - 09:09 am

GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal

Fierce Pharma

Thu, 12/5/24 - 11:39 am

GSK goes East again, snagging option on preclinical DualityBio ADC for $30M

Fierce Biotech

Wed, 12/4/24 - 10:58 am

antibody-drug conjugates

Sanofi announces its biggest China investment deal amid China-EU trade tensions

MSN/Reuters

Mon, 12/2/24 - 10:51 am

drug manufacturing

Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact

Fierce Pharma

Fri, 11/22/24 - 11:50 am

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll

Fierce Pharma

Wed, 11/20/24 - 08:41 pm

What might a Trump administration mean for the Biosecure Act?

Pharma Voice

Wed, 11/20/24 - 11:27 am

Pfizer makes $1B commitment in China to boost innovation, targets Chinese market

BioSpace

Fri, 11/8/24 - 11:53 am

AstraZeneca's China chief in custody, believes unrelated to insurance probe

MSN/Reuters

Wed, 11/6/24 - 08:13 pm

AstraZeneca stock tanks over fears of expanding China fraud probe

Fierce Pharma

Tue, 11/5/24 - 06:20 pm

Baxter exits China IV fluids market amid tough local competition, US shortage

Fierce Pharma

Thu, 10/31/24 - 09:21 am

Baxter International

AstraZeneca's China president faces 'ongoing investigation' by authorities in the country

Fierce Pharma

Wed, 10/30/24 - 11:43 am

Bristol Myers partner Zai Lab plots KarXT filing in China after trial win

Fierce Pharma

Tue, 10/29/24 - 08:00 pm

Bristol Myers Squibb

GSK to pay $300M to license drug it sees as potential lupus treatment

BioPharma Dive

Tue, 10/29/24 - 11:38 am

BeiGene, ex-AstraZeneca exec faces investigation in China: reports

Fierce Pharma

Fri, 10/25/24 - 11:40 am

Preparing for the US Biosecure Act - what does it mean for the pharma industry?

Outsourcing Pharma

Wed, 10/9/24 - 09:40 am

Kailera launches with $400M series A and clutch of Chinese obesity drugs

Fierce Biotech

Tue, 10/1/24 - 09:57 am

Kailera Therapuetics

Cerevel Therapeutics

Sanofi's Dupixent scores double COPD win in US, China

Pharmaphorum

Mon, 09/30/24 - 09:16 am

Gilead's Kite exits China cell therapy joint venture with Fosun Pharma

Fierce Pharma

Thu, 09/19/24 - 09:22 pm

Gilead Sciences

Fosun Kite Biotechnology

Biopharma prepares to pivot from China as Biosecure Act advances

Pharma Voice

Mon, 09/16/24 - 09:48 am

Complete Genomics

Pages